The FDA has made a purposeful choice to write in broad strokes, stopping short of detailing ways to execute DCTs.
The post New FDA Draft Guidance Signals Acceptance Of Decentralized Trials (When Done Right) appeared first on Above the Law.
from Above the Law https://ift.tt/1X2nsm8
via IFTTT